Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

40.24
Delayed Data
As of May 27
 +0.65 / +1.64%
Today’s Change
26.02
Today|||52-Week Range
52.33
-10.34%
Year-to-Date
Seattle Genetics Starts Trial on Acute Myeloid Leukemia Drug
May 26 / Zacks.com - Paid Partner Content